A Prospective Randomized Placebo-Controlled Double Blind Clinical Trial to Evaluate the Safety and Efficacy of CLBS03 (Autologous Ex Vivo Expanded Polyclonal CD4+CD25+CD127lo/-FOXP3+ Regulatory T-cells [Tregs]) in Adolescents with Recent Onset Type 1 Diabe v1

crossref（2024）

引用 0|浏览0

暂无评分

摘要

This protocol details a prospective randomized placebo-controlled double blind clinical trial to evaluate the safety and efficacy of CLBS03 (autologous ex vivo expanded polyclonal CD4+CD25+CD127lo/-FOXP3+ regulatory T-cells [Tregs]) in adolescents with recent onset Type 1 Diabetes Mellitus.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要